CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-08 | Watts Ryan J. President and CEO | Option exercise · Restricted Stock Units | −8,800 | 17,600 | ||
| 2021-02-07 | Schuth Alexander O. COO and Secretary | Option exercise | +4,250 | 538,812 | ||
| 2021-02-07 | Schuth Alexander O. COO and Secretary | Option exercise · Restricted Stock Units | −4,250 | 8,500 | ||
| 2021-02-07 | Krognes Steve E. CFO and Treasurer | Option exercise | +4,250 | 14,427 | ||
| 2021-02-07 | Krognes Steve E. CFO and Treasurer | Option exercise · Restricted Stock Units | −4,250 | 8,500 | ||
| 2021-02-07 | Ho Carole Chief Medical Officer | Option exercise | +4,250 | 169,391 | ||
| 2021-02-07 | Ho Carole Chief Medical Officer | Option exercise · Restricted Stock Units | −4,250 | 8,500 | ||
| 2021-02-04 | Schuth Alexander O. COO and Secretary | Sale | −1,579 | $66.65 | $105K | 542,983 |
| 2021-02-04 | Schuth Alexander O. COO and Secretary | Sale | −6,509 | $67.90 | $442K | 536,474 |
| 2021-02-04 | Schuth Alexander O. COO and Secretary | Sale | −1,912 | $68.61 | $131K | 534,562 |
| 2021-02-01 | Watts Ryan J. President and CEO | Sale | −14,222 | $68.21 | $970K | 2,308,761 |
| 2021-02-01 | Watts Ryan J. President and CEO | Sale | −3,552 | $69.17 | $246K | 2,305,209 |
| 2021-02-01 | Watts Ryan J. President and CEO | Sale | −560 | $69.69 | $39K | 2,304,649 |
| 2021-01-15 | Krognes Steve E. CFO and Treasurer | Sale | −14,801 | $70.10 | $1.0M | 985,199 |
| 2021-01-15 | Krognes Steve E. CFO and Treasurer | Sale | −12,981 | $70.96 | $921K | 972,218 |
| 2021-01-15 | Krognes Steve E. CFO and Treasurer | Sale | −8,071 | $71.99 | $581K | 964,147 |
| 2021-01-15 | Krognes Steve E. CFO and Treasurer | Sale | −14,147 | $73.01 | $1.0M | 950,000 |
| 2021-01-08 | Thornberry Nancy Director | Grant or award · Stock Option (right to buy) | +7,535 | 7,535 | ||
| 2021-01-08 | Thornberry Nancy Director | Grant or award · Restricted Stock Units | +2,511 | 2,511 | ||
| 2021-01-04 | Krognes Steve E. CFO and Treasurer | Grant or award · Restricted Stock Units | +30,000 | 30,000 |
Page 28 of 53 · 1,053 trades